Neuroblastoma

Usually affecting newborns and young children under the age of five, neuroblastoma is a rare but deadly form of paediatric cancer that originates in immature nerve cells. Though it can also arise in the neck, chest, abdomen, or spine, it most usually starts in the adrenal glands, above the kidneys. Though genetic changes during foetal development are thought to be involved, the precise origin of neuroblastoma is yet unknown.
The location and degree of dissemination of the tumour determine the different symptoms. They could call for stomach trouble or puffiness, tiredness, irritability, bone discomfort, loss of appetite, or inexplicable weight loss. Sometimes neuroblastoma might generate hormones that cause symptoms including elevated blood pressure, flushing, or too much perspiration.
Imaging exams (CT, MRI, MIBG scan), urine tests for catecholamines, and tumour biopsy constitute the diagnosis. The stage and risk classification determine the treatment choices; they could be surgery, chemotherapy, radiation therapy, stem cell transplant, immunotherapy, or focused therapy.
Although neuroblastoma can be aggressive—especially in high-risk cases—advances in paediatric oncology and tailored treatment programs have greatly enhanced the results. Effective management of the condition depends critically on early diagnosis and access to specialized care.